CAI FY 2016 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$294M+17.9% YoY

Gross Profit

$137M46.7% margin

Operating Income

$66M22.4% margin

Net Income

$6M2.0% margin

EPS (Diluted)

$0.31

Cash Flow

Operating Cash Flow

$129M

Free Cash Flow

-$122M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$2.1B

Total Liabilities

$1.6B

Stockholders' Equity

$458M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$294M	$250M	+17.9%
Gross Profit	$137M	$126M	+9.2%
Operating Income	$66M	$68M	-3.1%
Net Income	$6M	$27M	-77.7%